-
1 week ago | 
axios.com | Aaron Weitzman |Claire Rychlewski
Reliant Healthcare, a privately held ambulatory infusion provider, collected first-round takeover bids this week, two sources familiar with the process tell Axios. Why it matters: Reliant is primarily being marketed to private equity firms, which have demonstrated an insatiable appetite for infusion investments. Inside the room: Brentwood Capital is advising Reliant Healthcare, which generates about $8 million of EBITDA, the sources say.
-
2 weeks ago | 
axios.com | Claire Rychlewski
-
2 weeks ago | 
axios.com | Claire Rychlewski
Autism therapy provider Center for Social Dynamics will leverage its new partnership with Floreo to offer VR group therapy amid persistent clinician shortages. Why it matters: The partnership positions both companies for dealmaking in the coming year, the CEOs tell Axios. What's next: Goldman Sachs Alternatives-backed CSD is weighing acquisitions to expand throughout the U.S., CEO Kelly Bozarth says.
-
1 month ago | 
axios.com | Claire Rychlewski |Erin Brodwin
Paulus Holdings agreed to acquire Alto Pharmacy in a deal valuing the digital pharmacy business at $1 billion to $1.5 billion, per Bloomberg. Why it matters: The deal positions Paulus, backer of LetsGetChecked-owned Truepill, for a digital pharmacy roll-up at a time when solo startups in the sector have struggled with low margins. Catch up quick: Alto, backed by SoftBank Group, was last valued at $786 million, per PitchBook — a steep decline from the $1.8 billion valuation it garnered in 2020.
-
1 month ago | 
axios.com | Dan Primack |Claire Rychlewski
-
1 month ago | 
axios.com | Claire Rychlewski
The latest: Prospective buyers are mulling a combination of HealthEdge — being advised by Evercore and UBS — and UST-owned health insurance tech provider HealthProof, sources say. • HealthProof, which acquired government health program-focused technology company Advantasure in 2022, is pursuing its own process and generates $100 million of EBITDA, one source says. • HealthEdge and HealthProof have been partners for several years.
-
1 month ago | 
axios.com | Nathan Bomey |Claire Rychlewski
Walgreens Boots Alliance — whose namesake chain is one of the largest retailers in the U.S. and an iconic brand in the drugstore sector — has reached a deal to be taken private. Why it matters: The company has been struggling to keep up with nimbler retailers, rising medical costs, labor demands and digital pharmacy alternatives.
-
1 month ago | 
axios.com | Claire Rychlewski
How it works: Lumata offers between-visit virtual care management for patients with chronic eye diseases including diabetic retinopathy, macular degeneration and glaucoma. • CEO Landon Grace told Axios last year that the company is looking at partnering with pharmaceutical companies to expand their portfolios. The big picture: McKesson (NYSE: MCK) and Cencora (NYSE: COR) both pursued ophthalmology deals last year in an effort to control more of the high-dollar spend category.
-
1 month ago | 
axios.com | Claire Rychlewski
Sycamore Partners' potential buyout of Walgreens Boots Alliance would set the stage for a three-way breakup of the pharmacy chain, the Financial Times reports. Why it matters: It seems Sycamore has determined Walgreens is worth the sum of its parts. Zoom in: After taking Walgreens private, Sycamore plans to separate its U.S. pharmacy business Walgreens; U.K. chemist and retail group Boots; and specialty pharmacy unit Shields Health Solutions into three independent businesses.
-
1 month ago | 
axios.com | Aaron Weitzman |Claire Rychlewski
Warburg Pincus sold a majority stake in Modernizing Medicine to Clearlake Capital, valuing the EMR company at $5.3 billion, Axios confirmed. Why it matters: It's been a slow start to a year that was supposed to go gangbusters for private equity, but this deal could be the first domino. Zoom in: Summit Partners and ModMed cofounders Daniel Cane and Michael Sherling maintain a minority share, as first reported by the Financial Times. • ModMed declined to comment.
